At some point every growing clinic faces the same fork: hire someone internally to run marketing, or pay an agency. The decision is usually made on cost, which is the least useful way to make it, and reversed a year later at considerable expense.
The right answer depends on what stage the clinic is in. Agencies are better at building and scaling channels quickly. In-house teams are better at owning the parts of the funnel that live inside the clinic. Most successful clinics end up with a hybrid: strategy and patient conversation owned internally, channel execution bought.
What Actually Has to Get Done
Before choosing who does the work, be specific about what the work is. Clinic marketing is at least five distinct jobs: strategy and economics, channel execution, creative production, the follow-up and sales function, and measurement.
Bundling these into "marketing" is how clinics end up hiring a generalist who is genuinely good at one of the five and mediocre at the rest. Naming them separately makes the build-or-buy decision obvious job by job rather than as one lump.
Where Agencies Genuinely Win
Agencies bring pattern recognition. A firm running twenty clinic accounts has seen which offers work, which creative gets rejected, and how ad platforms behave in this category. A first-time in-house hire is learning that on your budget.
They also bring immediate capacity. Media buying, creative production, and landing page builds are specialized skills, and hiring all of them internally is expensive at a clinic's scale.
The third advantage is speed of change. If a channel stops working, a good agency shifts within a week. An in-house specialist hired for that channel represents a much harder decision.
Where In-House Genuinely Wins
Anything requiring proximity to the patient conversation belongs inside the clinic. Nobody at an agency will answer a lead in four minutes, learn why patients hesitated last week, or notice that the consult calendar is thin on Thursdays.
Institutional knowledge compounds internally and evaporates when an agency relationship ends. An in-house person who has heard nine hundred patient objections is a strategic asset. That knowledge does not transfer out with a monthly report.
And the sales function is where most clinic revenue is actually won or lost. Speed to lead, qualification standards, follow-up persistence, and close rate are all internal functions, and improving them usually returns more than improving traffic. That is the argument in patient acquisition cost for stem cell clinics.
The Split That Works for Most Clinics
Own the strategy, the economics, and the patient conversation. Buy the channel execution.
Concretely, the clinic owns: allowable acquisition cost, the offer, qualification standards, follow-up sequences, and the weekly numbers review. The agency owns: media buying, creative production, landing pages, and channel-level optimization against targets the clinic set.
This split keeps the irreplaceable knowledge inside and buys the specialized skills. It also makes the agency relationship measurable, because you gave them a number to hit rather than a vibe to pursue.
How to Evaluate an Agency
If you outsource, the evaluation matters more than the negotiation. Four questions separate serious firms from the rest.
Do they measure to revenue or to leads? A firm that reports cost per lead and cannot discuss cost per collected dollar will optimize toward cheap leads, which is not what you are buying.
Have they worked under medical advertising restrictions? Agencies new to the category learn compliance by getting your ads rejected and occasionally your account restricted. See why stem cell ads get rejected.
Who owns the assets? Ad accounts, pixels, landing pages, and creative should be in your accounts. If leaving means starting over, you are renting your history.
What do they need from you? A firm that never asks about close rate, show rate, or average case value is planning to optimize the part they can see and ignore the part that determines profit.
The Red Flags
Guaranteed patient volume, in a category where outcomes cannot be promised and platforms restrict claims, is a sign of either inexperience or worse. Long lock-in contracts before any performance data exists shift all the risk onto you. Refusal to give account-level access is the clearest signal to walk away. And an agency that talks about impressions and engagement in a $20,000-per-patient business has told you what they measure.
When to Bring It In-House
The usual trigger is scale. Once media spend is large enough that agency fees would fund a strong internal hire, and once the channel mix has stabilized, moving in-house often makes sense.
Do it in stages rather than at once. Bring the sales and follow-up function in first, since it has the highest return and lowest technical risk. Bring media buying in last, since it is the most specialized and the easiest to buy well. For how the internal roles are structured, see the stem cell clinic sales guide.
Frequently Asked Questions
How much should a clinic pay an agency?
Evaluate total cost, fees plus media, against acquisition cost rather than judging the fee alone. An agency charging more but producing patients under your allowable cost is cheaper than a low-fee firm producing patients above it.
Can one in-house marketing hire replace an agency?
Rarely at first. A single hire can own strategy, follow-up, and measurement well. Expecting the same person to also produce creative and buy media across platforms usually produces mediocre execution.
Should we use a general marketing agency or a medical specialist?
Specialists are worth a premium in this category, mainly for compliance and offer design. A general agency will spend your first three months learning constraints a specialist already knows.
What should we require in the contract?
Ownership of all accounts and creative, a notice period under ninety days, monthly reporting that includes revenue by source, and a defined performance target expressed in your allowable acquisition cost.